Efficacy of prazosin in the management of chronic congestive heart failure: A 6-month randomized, double-blind, placebo-controlled study
- 1 May 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 51 (8) , 1346-1352
- https://doi.org/10.1016/0002-9149(83)90310-7
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Ambulatory prazosin treatment of chronic congestive heart failure: Development of late tolerance reversible by higher dosage and interrupted substitution therapyAmerican Heart Journal, 1981
- Increased Plasma Norepinephrine Levels During Prazosin Therapy for Severe Congestive Heart FailureAnnals of Internal Medicine, 1980
- Development of pharmacodynamic tolerance to prazosin in congestive heart failureThe American Journal of Cardiology, 1979
- Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failureThe American Journal of Cardiology, 1979
- Attenuation of Prazosin Effect on Cardiac Output in Chronic Heart FailureAnnals of Internal Medicine, 1979
- Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.Circulation, 1979
- PrazosinNew England Journal of Medicine, 1979
- Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failureThe American Journal of Medicine, 1978
- Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.Circulation, 1978
- Effects of prazosin on forearm resistance and capacitance vesselsClinical Pharmacology & Therapeutics, 1977